Industry Consolidation page 1
Industry Consolidation page 2
Industry Consolidation page 3

Industry Consolidation

Embed Size (px)

Text of Industry Consolidation

  • OIS@AAO INDUSTRY CONSOLIDATION

    Jim Mazzo Chairman & CEO - AcuFocus October 16, 2014

    UNKNOWN

    THE

    GOOD BAD THE

    & T

    HE

  • Impact of Consolida@on on Innova@on

    Poten3al for greater resource alloca3on to disrup3ve innova3ons

    Synergis3c benefits of combined core R&D competencies

    Larger commercializa3on network to speed new innova3ons to market

    Disrup3on of innova3on cycle and shiIs in priori3es

    Loss of ins3tu3onal knowledge & exper3se

    Reduced R&D spending; increased compe33on for clinical & regulatory resources

    Are physicians & pa3ents beLer served over the long-term? How do changes in the compe33ve landscape affect the industry? Can merged companys innova3on engine truly be more efficient and prolific?

    THE BAD THE GOOD

    THE UNKNOWN

  • Meet the Panel Jeff George President & Global Head, Alcon William Link, PhD Managing Director, Versant Ventures Ashley McEvoy Group Chairman, Johnson & Johnson David PyoQ CEO, Allergan Murthy Simhambhatla, PhD President, AbboQ Medical Op@cs